In addition, prostate cancer cell-derived exosomes can promote osteoclast differentiation without the assistance of RANKL, suggesting that prostate cancer cell-derived exosomes can activate non-RANKL-dependent pathways that promote osteoclast differentiation. The gene discussed is TNFSF11; the disease is prostate carcinoma.